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Although the constituent of the hemolytic streptococcus cell, which 
determines  specificity  in  each  of  the  various  types included  within 
group A, has been considered a  protein,  attempts  to demonstrate  its 
antigenicity  after  separation  from  the  cell  have  not  been  entirely 
successful.  This  paper  gives a  more  detailed  study of this  subject. 
It seems probable that in some instances the chemical procedures used 
to isolate the type-specific substances tended to degrade the proteins, 
and thus render them less antigenic.  The early experiments  (1) with 
the type-specific protein  M  showed that  although  the  sera produced 
by the injection of whole streptococci gave specific precipitin reactions 
with this partially  purified extract,  the injection of the protein  solu- 
tion  itself  failed  to  stimulate  type-specific  antibody  production  in 
rabbits  or  guinea  pigs,  as  shown  by  the  following  negative  tests: 
precipitin  reaction,  agglutination,  passive protection in mice, passive 
and active anaphylaxis in guinea pigs. 
By extracting ground streptococci with increasingly alkaline solutions, Heidel- 
berger and Kendall (2) isolated a fraction which stimulated type-specific precipitin 
formation  when injected  into  rabbits;  but these  sera were not tested  for their 
ability  to protect  mice passively. 
Mudd  and  his  collaborators  (3)  have  reported  the isolation of an  antigenic 
fraction  from  group  A  hemolytic  streptococci  which they have  named  labile 
antigen?  They postulated that the labile antigen is a complex molecule contain- 
ing the type-specific protein  M in addition  to several other  serologicaUy  active 
constituents.  Besides  absorbing type-specific agglutinins, opsonins, and protec- 
On  the  basis  of  recent  unpublished  findings of Mudd,  Lackrnan,  Pettit, 
and Morgan, Dr. Mudd has informed us that  these authors  now prefer to sub- 
stitute the term "nucleoprotein  aggtutinogen" for "labile antigen." 
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tive antibodies from antibacterial serum,  the labile  antigen, when injected into 
rabbits, induced antibodies which gave partly type-specific  precipitin reactions, 
but these antisera were not tested for protective action in animals. 
In  1937, Stamp and Hendry (4)  isolated a  fraction from a  group A type 3 
hemolytic streptococcus (strain Richards), which produced active immunity when 
injected into mice.  47 per cent of the immunized animals were protected against 
100 minimal lethal doses  of the homologous  organism.  The specificity of this 
immune response, however, was not tested. 
EXPERIMENTAL 
AS  a  starting  point  for  obtaining  the  type-specific  substance  in 
antigenic form, it was thought promising to use bacteria ground in the 
cold, as suggested by Mudd and his collaborators.  The first untreated 
saline  extracts  of  such  material,  injected  into  rabbits,  induced  the 
formation  of  slight  amounts  of  antibody,  as  demonstrated  by  pre- 
cipitin  and  agglutinin  tests  and  the passive  protection of mice,  but 
the  antibody titers of these sera were very low. 
Because  of  the  large  quantities  of  extract  required  to  immunize 
rabbits, it was decided to immunize mice and to test their active im- 
munity  following the  method  of  Stamp  and  Hendry,  using  the  per 
cent of survival of actively immunized mice as the index of antigenicity 
of  various  preparations.  In  numerous  experiments  this  technique 
proved to be a  rough but convenient way of testing various fractions. 
Methods 
Selection of Strains.--Since the antigenicity of the extracts was to be tested by 
actively immunizing  mice,  it was  essential to  use only highly  mouse-virulent 
strains which would  be suitable for testing the degree of immunity in mice.  It 
seemed probable, furthermore, that virulent cultures would yield larger amounts 
of antigenic material  than  avirulent ones.  One  strain  each of three different 
types within  group A was  used  for preparing antigenic  extracts and one addi- 
tional strain of each of these types was employed for testing the immunity. 
Description  of Strains. s- 
Type 1 :s  1.  Strain $118 was isolated in Texas in 1918 from the pleural fluid 
of a patient with bronchopneumonia following measles  (6). 
2.  Strain T1 is Griflith's type 1 strain, S. F. 130/2 (7). 
Type 3:  1. Strain  D58  is  the  strain  Richards,  isolated by Colebrook from 
2 Strains T1 and T14 were kindly sent by Dr. F. Griffith, strain I)58 by Dr. 
T. C. Stamp, and strain C203 by Dr. M. B. Kirkbride. 
8 Types are designated according to Griflith's classification  (5). GEORGE  K.  HIRST  AND  REBECCA  C.  LANCE~FIELD  427 
puerperal septicemia (4).  It was obtained in a  virulent state following mouse 
passage. 
2.  Strain C2034 was isolated by Dochez about 1921 from a patient with scarlet 
fever, and obtained in virulent form in 1927. 
Type  14:  1.  Strain $23  was  isolated in  Texas in  1918  from  the  throat of a 
patient with lobar pneumonia (6). 
2.  Strain  T14 is strain Barker, a  representative of type  14. 
Virulence.--At  the  beginning  of  this  experiment,  three  of  the  six  strains, 
namely $23, C203, and D58, were virulent enough to kill mice in doses of 10 -s cc. 
to  10 -s cc. of 6  to  12  hour cultures.  Strain T14  was moderately virulent and 
required only six to eight mouse passages to reach the same degree of virulence. 
The other two strains, $118  and T1, were so degraded that they produced typ- 
ically glossy colonies and failed to yield demonstrable type-specific substance in 
extracts of ordinary concentration.  They were so avirulent that 0.1  cc.  to  0.5 
cc.  of a  young culture was  required to  kill mice.  By repeated mouse  passage 
(25 passages for $118 and 60 passages for T1) it was possible to render these cul- 
tures virulent. 
The chief method used in the preparation of antigenic extracts was as foUows :-- 
Medium.--The bacteria used for preparing antigenic extracts were grown  in 
the type of broth developed by Todd and Hewitt (8), modified chiefly by the sub- 
stitution of beef heart/or horse meat.  The fact that the broth is sterilized by 
filtering through Chamberland B filters, rather than by heating, increases its value 
as a  medium but also adds an element of danger in its use  , since contaminants 
sometimes grow in uninoculated flasks which have been incubated for 3 or 4 days. 
By seeding the broth immediately after filtration with a very large inoculum, and 
then limiting the incubation to 4 hours, pure cultures were obtained in all except 
one instance. 
During the early stages of growth in this broth, large capsule-like areas could 
be seen surrounding the organisms in moist India ink preparations.  These cap- 
sules increased markedly in size and were maximal in about 4  hours, following 
which they rapidly became smaller.  The bacteria at this early stage were very 
difficult to throw down in the centrifuge, but following heating at  56  °, or after 
more prolonged incubation, the capsules disappeared and the bacteria were then 
easily packed on centrifugation, an observation also made by Seastone (9)  and 
more recently by Loewenthal (10). 
These capsules resembled those described by Seastone and later by Ward and 
Lyons  (11),  in young cultures of hemolytic streptococci grown  in  whole blood, 
in  that  they were present only in young cultures and were not correlated with 
4 While Dr. Griffith has placed this strain in type 1 by means of slide agglutina- 
tion, work carried out in this laboratory indicates that, on the basis of protection 
and precipitin tests, it falls in type 3.  Further studies are being made here on the 
interrelationships of strain C203  and types 1 and 3. 428  GROUP  A  HEMOLYTIC  STREPTOCOCCI 
mouse virulence, but they differed in that we could not stain them by ordinary 
methods.  The difficult question of the significance of capsules for the hemolytic 
streptococcus has been reviewed by a number of authors (9, 10, 12), but in these 
experiments the presence of a  capsule was taken to mean that the cultures were 
in a  period of optimal physiological activity. 
Cotleaion of Bacteria.--The  broth was filtered while still hot through Chamber- 
land filters and was then cooled to 37°C.  64 liters were inoculated with 25  cc. 
per liter of an actively growing 4 hour culture.  After 4 hours' growth, samples 
were removed from each flask and plated on blood agar to test the purity of the 
culture.  The culture was then stored at 0°C.  overnight, and kept chilled while 
running  through  a  Sharpies centrifuge on  the following day.  The  caked bac- 
terial sediment was suspended in about 200 cc. of cold saline by grinding it in a 
large, previously chilled mortar and pressing it through sterile gauze, stretched 
over a wire strainer, into another cold container in order to break up dumps and 
facilitate uniform heating during the process of heat-killing.  The suspension was 
then transferred to a glass stoppered pyrex bottle, and the bacteria killed quickly 
by the following procedure: A  thermometer was inserted into the bottle so that 
the temperature could be accurately adjusted.  The temperature was raised with- 
in 1 minute to 56°C. by the addition, while shaking, of about 400  cc. of boiling 
saline.  The stopper was then covered tightly with a  rubber cap; and the bottle 
was completely immersed for 15 minutes in a  56°C. water bath.  Sterility tests 
showed that all the bacteria in this heavy suspension were killed by the end of this 
time.  The suspension was rapidly cooled by placing the  bottle under running 
water and then centrifuged in 50 cc. wide mouthed tubes; the superuatant  fluid 
was discarded.  The tubes, containing not more  than 3 gm. dry weight of bac- 
terial sediment, were placed in a  CO2-ice-acetone mixture.  While freezing, the 
bacteria were easily distributed over the sides of the tube with a  spatula.  The 
completely frozen organisms were dried by means of the Flosdorf-Mudd lyophile 
apparatus (13). 
Extraction.--Preparatory  to  extraction,  the  bacteria were  ground  in  a  ball 
mill consisting of a  1 liter spherical heavy glass flask and 500  one-quarter inch 
stainless steel balls (14).  At first the grinding was done at  -73°C. as advocated 
by Mudd (15).  Later, however, it was found that  satisfactory results could be 
obtained by grinding 1 gin. of  dried organisms in each flask for one-half hour at 
room temperature.  This procedure rendered approximately 75  per cent of the 
cocci Gram-negative without  causing much  change in  their morphology.  The 
organisms from twelve flasks were collected in 500  cc. N/10 HC1 and extracted 
at 37°C. for 24 hours.  Mter centrifugation the supernatant extract was removed; 
250  cc. N/10 HC1 were added to the organisms which were then extracted for a 
second 24 hours.  This procedure was repeated on a  3rd day.  The yield of ac- 
tive material from the second and third extractions tended to be larger than that 
from the first; but since further extractions resulted in smaller yields, the bac- 
terial residue was discarded. 
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extracts with N/1 NaOH a  precipitate began to form as pH 4.0 was approached 
and became maximal at about pH 4.5.  In the case of the first acid extract it 
was necessary to bring the pH to 5.0 before flocculation occurred.  After standing 
overnight in the ice box the precipitates were thrown down in a centrifuge and  the 
supernatant  fluids discarded.  The  combined precipitates from  various  extrac- 
tions were taken up in x¢/15 phosphate buffer solution at pH 7.2 but most of the 
precipitate was insoluble and was discarded.  N/1  HC1 was slowly added to the 
supernatant fluid.  As pH 5.5 was approached a precipitate began to form which 
was maximal at pH 4.5.  This was allowed to stand overnight in the ice box and 
the  precipitate  separated  the  following morning.  The  supernatant  fluid  was 
discarded, and now nearly all the precipitate was dissolved in 50 cc. of ~/15 phos- 
phate buffer at pH 7.2.  After removal of the small amount of insoluble material 
the solution was filtered through a  Berkefeld N  filter. 
The filtrate was distributed in amounts suitable for one day's injections and 
then frozen and dried to prevent deterioration.  In order to estimate the dosage, 
the total nitrogen and that precipitated by trichloroacetic acid were determined 
by means of the micro Kjeldahl method.  The nitrogen precipitated by trichloro- 
acetic acid was always between 50 and 60 per cent of the total nitrogen.  Since 
it was felt that  the antigenic activity probably resided in  the protein fraction, 
the dosage in all experiments was calculated as 6.25  times the nitrogen content of 
the material precipitated by trichloroacetic acid; and  the total yield calculated 
in the same way was about 0.6 per cent of the dry weight of the bacteria. 
Serological Reactions Obtained with the Extract.--Different  preparations of anti- 
gen  reacted  type specifically to  about  the same  dilution, usually  1:200,000  in 
precipitin tests with homologous type-specific sera.  The dilution was calculated 
in  the  same way as the dosage employed in immunization.  No group-specific 
polysaccharide C could be detected in these extracts when tested with sera potent 
in anti-C precipitins nor could this carbohydrate be split off by heating the solu- 
tion at  100°C.  with N/20 HCI. 
The  method  of  extraction  and  partial  purification  outlined  was 
adopted  as  the  procedure  of  choice  for  the  chief experiments of this 
investigation, but  several less successful methods  of preparation  were 
tried in numerous  other experiments. 
Active Immunization  of Mice 
The mice used in these experiments were the Rockefeller strain.  When possi- 
ble, mice weighing 24 to 26 gin. were used for active immunization, since they 
seemed to  give better results  than  smaller ones.  The  dried antigenic extracts 
were  dissolved in  physiological sodium  chloride solution  just  before  injection, 
which was made intraperitoneally on 3  successive days with a  rest period of 4 
days  between  courses.  Usually  three  or  four  courses  were  given.  The  im- 
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after  the  last  injection  of  the  antigen.  Experiments  were  terminated  after  2 
weeks'  observation. 
The mice in the first experiment (Table I) were immunized for 4 weeks with an 
TABLE  I 
Active Protection Test in Mice 
Titer of Homologous Immunity 
__~  __10-2  cc.  __lq 
1  IDlday  D 
2  D1  "  D 
3  D1  "  D 
4  D1  "  D 
5  D1  "  D 
6  D1  "  D 
7  D1  "  D 
8  D1  "  D 
9  D1  "  D 
10  D  1  "  D 
11  D  1  "  D 
12  D  1  "  D 
D  t3  D  1  " 
14  D  1  " 
15  D  1  " 
16  D  1  " 
17  D  1  " 
18  D  1  " 
19  D  i  " 
20  D  1  " 
Mice immunized  with  extract  of type  1 strain,  Sl18  Untreated  controls 
Inoculated  with  the followir  : amounts  of S118 
"3 CC. 
[ day 
[  " 
[  " 
[  " 
[  tc 
[  " 
[  " 
[  " 
[  " 
[  " 
[  " 
] days 
S 
S 
S 
S 
S 
S 
S 
10-4cc.  10-5 cc.  I  lq  co.  I  10~'cc.  I  10-'Zcc.  108cc. 
D  1 da  3 
D  2 da) 
D  2  " 
D  4  " 
D  6  " 
D  7 
D  10 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
D  1 day  1  D q 
co. 
day  day 
rs  D  1  "  ,]  D  days 
D  1  "  [D  " 
D2 days]  D  " 
D  2  "  I D  " 
"  D  2  "  S 
"  D  3  "  S 
D  3  "  S 
D  3  "  S 
D  3  "  S 
D  3  "  S 
D  1 day ] 
D  3 days[ 
DSS"  i 
S 
S 
S 
S 
S 
S 
S 
DldaYi  Dlday 
D1  "  D1  " 
D1  "  D1  " 
D  1  "  D  1  " 
D  1  "  ID  1  " 
D1  "  D1  " 
D  1  "  D  1  " 
D1  "  D1  " 
D  1  "  D  1  " 
D1  "  D1  " 
D1  "  D1  " 
D1  "  iD1  " 
D  2 dayslD 1  " 
I 
D2  "  D2day~ 
D  3  "  D 3  " 
D  3  "  D 3  " 
S  D 3  " 
S  D  3  " 
S  D  5  " 
S  S 
The mice were immunized for 4 weeks: 3 injections of 0.01 mg. each were given 
the 1st week, 3 of 0.02 rag. each the 2nd, 3 of 0.04 rag. each the 3rd and 4th. 
The protection tests were performed as follows:  A  fresh 16 hour broth culture 
was serially diluted with broth so that the amount inoculated was contained in 
0.5  cc.  The  inoculations  were  intraperitoneal.  The  untreated  controls  corre- 
sponded in age and weight with the immunized animals.  The number of strepto- 
cocci injected was estimated in colony counts from poured blood agar plates con- 
taining  10 -8  cc.,  10 -~  cc.,  and  10 -s  cc.,  respectively,  of  the  culture  used  for 
inoculating the mice.  The number of colonies in 10 -s cc. varied from two to six 
in different experiments. 
In all experiments S indicates animals which survived at least 2 weeks, and D 
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extract of strain Sl18 in the manner indicated in Table I.  A total dosage of 0.33 
mg. was given to each animal.  1 week after the last injection, they were divided 
into six groups of 20 mice each, and each group was injected with a different dose 
of an overnight culture of strain  $118.  None  of  the  mice  receiving  1,000,000 
M.L.D. (10 -2 CC.) survived, but  in  all  the  groups  receiving smaller doses enough 
animals survived to show definite  protection against  the homologous organism. 
The  second experiment  (Table  II)  was  designed  to  test  whether  the active 
immunity induced by these  antigens  was  type-specific.  "Three sets of 84 mice 
were immunized for four courses with extracts of streptococci of three different 
types  (types  1, 3, and  14).  The mice received the same  amounts  of  antigenic 
extract as those in the first experiment.  1 week following the last dose of anti- 
gen each group was subdivided into six subgroups of 14 mice each.  Six strains 
were used as test inocula, two each of types 1, 3, and 14.  Each subgroup received 
10 -6 cc. of culture diluted in broth.  This small dose, containing 10 to 100 M. L. D., 
which killed all the control animals regularly, was selected in order to detect even 
slight evidence of cross protection. 
In each case, good protection was demonstrated against 10 to 100 lethal doses 
of streptococci of the homologous type, as there were 93 per cent survivors in type 
1, 93 to 100 per cent in type 3, and 43 to 50 per cent in type 14.  On the other 
hand,  comparably immunized mice, when inoculated with  heterologous strains, 
showed only slight or no immunity.  Some protection against the type 1 cultures 
was  afforded  to  mice  immunized  with  heterologous  extracts,  but  little  if  any 
cross immunity was found where types 3 and  14 were used as test inocula.  In 
every case type-specific immunity was clearly greater than the immunity against 
heterologous types.  It is probable that if a larger dose of culture had been used, 
the  immunity  induced  by  immunization  with  extracts  would  have  appeared 
strictly  type-specific. 
Type-Specific  Immunization of Rabbits with Extract 
Mter completing the experiments on active immunity in mice, an attempt was 
made to immunize rabbits with the same antigenic extract.  The immunity was 
tested  by protection  of mice by the sera  of these  animals.  The  rabbits  were 
treated as shown in Table III.  During immunization the response to the antigen 
was determined by precipitin tests with the homologous M  extract. 
These tests showed that the sera of the two rabbits immunized with 
Sl18  extract  (rabbits  R47-08  and  R47-09)  contained  no  precipitins 
against  the  homologous  extract  at  the  end  of  the  third  course,  but 
both had precipitins  and protective  antibodies  at the  end of the fifth 
course.  The  rabbit  given  seven  courses  showed no  increase  in  anti- 
body titer  over that  reached  at the end of the fifth series.  The  sera 
of the two rabbits  (R47-22  and R47-23)  similarly immunized with  an TABLE  II 
Active Protection Test in Mice 
Type  Specificity of Immunity 
Immunized mice 
Inoculated with 104 cc. of 
Immunized  Mouse  Type I  strains  Type 3  strains  Type 14  strains  with extract  No. 
of  strain 
Sl18 
(type 1) 
D58 
(type 3) 
$23 
(type 14) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
S118  I  T1 
(Homologous) 
D  7 days 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
Dlday 
D1 
D1  " 
D  2 days 
D  2  " 
D  2  " 
D  2  " 
D  2  " 
D  3  " 
D  3  " 
S 
S 
S 
S 
D  lday 
D1  " 
D1  " 
D1  " 
D1  " 
D  2 days 
D  2  " 
D  2  " 
D  2  " 
D  2  " 
D2  " 
S 
S 
S 
D  1 day  D  1 day 
S  D1  " 
S  D1  " 
S  D1  " 
S  D1  " 
S  D1  " 
S  D1  " 
S  D  2 days 
S  D  2  " 
S  D  2  " 
S  D  2  " 
S  D  2  " 
S  D  3  " 
S  D  3  " 
D58  C203 
D  1day 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D  2 day, 
D  2  " 
D2  " 
D  2  " 
D  2  " 
(Homologous) 
Dlday  S 
D1  "  S 
D1  "  S 
D  2 days  S 
D  2  "  S 
D  2  "  S 
D  2  "  S 
D  2  "  S 
S  S 
S  S 
S  S 
S  S 
S  S 
S  S 
D  1 day  D  1 day 
D1  "  D1  " 
D1  "  D1  " 
D1  "  D1  " 
D1  "  D1  " 
D  2 days  D  1  " 
D  2  "  D  1  " 
D2  "  D1  " 
D2  "  D1  " 
D2  "  D1  " 
D  3  "  D  1  " 
D3  "  D1  " 
S  D  2 days 
S  D  2  " 
D  3  days 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
S 
D  1 day 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D  2 days 
D  2  " 
D2  " 
D  2  " 
D  2  " 
$23  T14 
Dlday  Dlday 
D1  "  D1  " 
D1  "  D1  " 
D1  "  D1  " 
D  1  "  D  2 days 
D2days  D2  " 
D  2  "  D  2  " 
D  3  "  D  2  " 
D  3  "  D  3  " 
D  3  "  D  3  " 
D  5  "  D  3  " 
D  5  "  D  3  " 
D  9  "  D  3  " 
S  D  5  " 
Dlday  Dlday 
D  1  "  D  2  days 
D1  "  D2  " 
D  1  "  D  2  " 
D2days  D2  " 
D  2  "  D  2  " 
D  2  "  D  2  " 
D  2  "  D  2  " 
D  3  "  D  2  " 
D  3  "  D  2  " 
D  3  "  D  3  " 
D  7  "  D  3  " 
D  7  "  D  3  " 
S  D  8  " 
(Homologous) 
D  1  day  D  lday 
D  1  "  D  2 days 
D  2  lay  D  2  " 
D5  --  D2  " 
D  5  "  D  3  " 
D  6  "  D  3  " 
D  7  "  D  3  " 
D  9  " 
S 
S 
S 
S 
S 
S 
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Untreated  virulence control mice 
I  Inoculated with 
Mouse  No.  Type 1 strains  Type 3 strains  Type 14 strains 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
S118 
D  lday 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D  5 days 
D  1 day 
D1  " 
D1  " 
D1  " 
S 
D  lday 
S 
S 
S 
S 
D 
D 
D 
D 
D 
D 
D 
D  " 
D  " 
m 
m  " 
D  " 
D  " 
m  " 
D  1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D  2 days 
D  2  " 
D  2  " 
S 
S 
D58  C203 
D  1 day  D  1 day 
D  1  "  D  1  " 
D  1  "  D  1  " 
D  1  "  D  1  " 
D1  D  1  " 
D1  D  1  " 
D1  D  1  " 
D1  D  1  " 
D1  D  1  " 
D  1  D  2 days 
D1  D  2  " 
D1  D  2  " 
D  1  "  D  2  " 
D2days  D15  " 
D  1 day  D  1 day 
D  1  "  D  1  " 
D  1  "  D  1  " 
D  1  "  D  2 days 
D3days  D  9  " 
D  1 day  D  2  " 
D  1  "  D  2  " 
D2days  D  2  " 
D  2  "  D  2  " 
S  S 
$23  T14 
D  1 day  D  1 day 
D1  "  D1  " 
D1  "  D1  " 
D1  "  D1  " 
D1  "  D1  " 
D1  "  D1  " 
D  1  "  D  2 days 
D1  "  D2  " 
D1  "  D2  " 
D2days  D2  " 
D  2  "  D  2  " 
D  2  "  D  2  " 
D  2  "  D  2  " 
D  2  "  D  7  " 
D  1 day  D  2  " 
D1  "  D2  " 
D2days  D2  " 
D  2  "  D  2  " 
S  D  2  " 
D2days  D  lday 
S  D  2 days 
S  D  2  " 
S  D  2  " 
S  S 
extract of strain D58, contained demonstrable type-specific precipitins 
and protective antibodies after 3 weeks' immunization; and the titer 
was increased following 2 weeks' further immunization. 
The  capacity  of  these  sera  to  protect  mice  was  tested  with  six 
different strains  of hemolytic streptococci,  representing three types 
(Table  IV).  The  Sl18  serum was  a  pool  of bleedings from rabbit 
R47-08  after the fifth and  seventh courses of injections of antigen. 
The D58 serum was taken from rabbit R47-23 after the fifth course. 
Although the cultures used in the passive protection experiments were 434  GROUP  A  IIEMOLYTIC  STREPTOCOCCI 
somewhat less virulent than  usual,  as shown by the  survival of some 
control  mice,  nevertheless,  there  was  distinct  protection  against 
1,000  to  100,000  M.L.D. of  the  homologous  type  streptococci  with 
some irregular deaths.  The few survivals among animals tested with 
heterologous  strains  were  very  irregular,  and  the  results  in  general 
show strict type specificity in these passive protection tests. 
TABLE  III 
Protocol  of Immunization  of Rabbits  with  Extracts 
Course  of  Rabbits R47-08 and R47-09" with Sl18  Rabbits R47-22 and R47-23 with D58 
injection  extract  extract 
1st 
2nd 
3rd 
4th 
5th 
6th 
7th 
2.5 rag. daily for 5 days 
4.3  "  "  "  "  " 
5.0  "  "  "  "  " 
Test bleeding 
10.0 rag. daily for 5 days 
10.0  "  "  ' ....  ' 
50 cc. bleeding 
10.0 mg. daily for 5 days 
20.0  "  "  "  "  " 
Final bleeding 
2.5 rag. daily for 5 days 
2.5  "  "  "  "  " 
5.0  "  "  "  "  " 
Test bleeding 
5.0 mg. daily for 5 days 
10.0  ....... '  " 
Final bleeding 
Immunizing material was dissolved in saline, 1 to 2 cc. and given intravenously. 
There were 2 days of rest between each course except where a bleeding was taken, 
in which case the interval was a week. 
* The final bleeding from rabbit K47-09 was taken after  the  sixth  course  of 
injections. 
Precipitin  Reactions  with  Anti-Extract  Sera 
In Table V  are shown  the  precipitin  reactions with  samples of the 
same sera used in  the  passive protection  tests recorded in Table IV. 
The  M  substances  used  as  reagents  were  extracted  with  N/20  HC1 
in a  boiling water bath as previously described  (16).  The immediate 
reactions  were  strikingly  type-specific, but  on  standing  overnight  in 
the  ice  box  the  somewhkt  confusing  cross  reactions  appeared.  The 
latter are recorded in the table.  The type  1 serum was not very po- 
tent but reacted most strongly with extracts of the  homologous type 
strains,  Sl18  and  T1.  It also gave weak reactions  with  all three  of 
the  type  3  extracts  used  but  none  with  the  type  14  extracts.  The 
much  more  potent  type  3  serum  gave  good  immediate  precipitates GEORGE  K.  HIRST  AND  REBECCA  C.  LANCEFIELD  435 
with  extracts  of  all  the  homologous  type  strains  (T3,  D58,  C203), 
and  weaker  reactions  with  the  type  1  extracts.  With  type  14  ex- 
tracts,  the  type reactivity of which had  been previously established 
by testing with antibacterial sera, this serum (R47-23) gave only traces 
of  precipitin  reaction.  Neither  serum  contained  group-specific 
antibody, as indicated by their failure to precipitate with a  solution 
of group-specific C  polysaccharide which,  in  the dilutions  used,  reg- 
ularly  precipitated  sera  known  to  contain  the  group-specific  anti- 
C precipitin. 
It is highly probable that the cross reactions in the precipitin tests 
are due  to the presence of non-type-specific antibodies in the  rabbit 
serum and of non-type-specific precipitinogens in the M  extracts used. 
Absorption of Antibacterial  Serum with Extracts 
In order to test the evidence identifying this antigen with the sub- 
stance in intact streptococci which stimulates  the production of pro- 
tective antibodies in rabbits, the antigen was used to absorb protective 
antibody  from  a  serum  made  by  immunizing  a  rabbit  with  whole 
streptococci.  Since  Mudd  and  his  collaborators  (3)  state  that  the 
type-specific protective antibody cannot be absorbed by the M  frac- 
tion, extracted with N/20 HC1 in a boiling water bath, another sample 
of the serum was absorbed with the M  substance so prepared. 
A rabbit was immunized chiefly with heat-killed but also with living culture 
of the type 1 strain, T1.  Its serum gave a strong precipitin reaction with the 
homologous  M  antigen, and  regularly protected mice against  1,000,000 ~x.L.D. 
of type 1 strains.  One portion of serum was absorbed with a known antigenic 
extract of strain Sl18 (lot 61, made in the same manner as that used as antigen 
for  the  active and  passive  immunization experiments).  Another  portion  was 
absorbed with an M extract of strain Sl18 made with N/20 HC1 in a boiling water 
bath.  Neither solution contained demonstrable group-specific C polysaccharide. 
The optimal proportions point for the precipitation of the serum by each antigen 
was  determined by  titration  (17),  and  the  solutions  of  antigens  were  added 
to the respective sera in double the optimal proportions.  Mter  incubating the 
mixtures at 37  ° for 2 hours and keeping them in the ice box overnight, the precipi- 
tates were removed and discarded and more of the respective antigen was added 
to the partially absorbed sera.  Practically complete absorption was  indicated 
by the lack of further precipitation with the lot 61 antigen and by the mere trace 
of precipitate with the M extract prepared by the older method.  Serial dilutions 
of each absorbed serum and of a control lot of the same serum unabsorbed were TABLE  IV 
Passive  Protection  Test  in  Mice  --Type  Specificity  of Immunity 
Serum from rabbit R47-08 immunized with SIt8 (type l) extract 
Mice inoculated with test culture 
Type 1 strains  Type 3 strains  Type 14 strains 
C2O3 
Dose 
10-3 
10-4 
10-5 
10-6 
10-7 
Mouse 
No. 
Sl18  -. T  __ 
(Homologous) 
D  1 day 
D1  " 
S 
S 
D  3  days 
S 
S 
S 
D  3  days 
D  4  " 
S 
S 
D2  days 
S 
S 
S 
D58 
D  1 day 
D1  " 
S 
S 
S 
S 
S 
S 
S  D  1 day 
S  D1  " 
S  D1  " 
S  D  2 days 
S  D  Ida), 
S  D1  " 
S  D  2 days 
S  D  2  " 
S  D  2  " 
S  D  2  " 
S  D  3  " 
S  D  3  " 
Dlday 
D1  " 
D1  " 
D1  " 
D  1  " 
D1  " 
D1  " 
D  2  days 
D1  day 
D1  " 
D2  days 
D2  " 
$23  TI4 
D  1  ,  D  1 day 
D2  's  D1  " 
D  4  D  8 days 
D4  S 
D  3  D  2 days 
D3  D4  " 
D9  D5  " 
S 
D2days  D3days 
D  3  "  D  3  " 
D  4  "  D  6  " 
S  S 
Virulence  controls:  no serum 
10-5 
lO-S 
lO-r 
lO-S 
D  1 day 
D1  " 
D1  " 
D1  " 
D1  " 
D  2 days 
D  2  " 
D  2  " 
D  1 day 
D2  days 
D  2  " 
S 
D  3  days 
S 
S 
S 
Dlday 
D1  " 
D1  " 
S 
D  1 day 
D1  " 
D1  " 
S 
D  3  days 
S 
S 
S 
D1  day 
S 
S 
S 
D  1 day 
D1  " 
D2  days 
D2  " 
D1  day 
D2  days 
D2  " 
D2  " 
D  1 day 
D  2 days 
D  2  " 
D  2  " 
D  5  " 
S 
S 
S 
D  1 day 
D1  " 
D1  " 
D1  " 
D  1  " 
D1  " 
D1  " 
D1  " 
D  1  " 
DI  " 
D1  " 
D  10 day~ 
D1  day 
D1  " 
D4days 
D  1 day 
D  1  " 
D2  days 
S 
D  1 day 
D  1  " 
S 
S 
D1  day 
S 
S 
S 
D1  day 
D1  " 
D2  days 
S 
D  lday 
D  2  days 
S 
S 
S 
S 
S 
S 
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Serum from rabbit R47-23 immunized with D58 (type 3) extract 
Mice inoculated  with test culture 
Type 3 strains  Type 14 strains 
$23  T14 
10-~ 
10-3 
10-4 
10-~ 
10-6 
10-~ 
1 strains  Type 
Dose  Mouse 
No.  SI18  T1 
CC. 
10-1 
2 
3 
4 
D  lday 
D  2 days 
D  2  " 
D  2  " 
D  lday 
D  2 days 
S 
S 
D  3 days 
D  3  " 
D  3  " 
S 
D58  1  C203 
(Homologous) 
D  1 day 
D1  " 
D1  " 
D1  " 
D  12 days 
S 
S 
S 
D  1 day  D  1 day 
D1  "  D1  " 
D1  " 
S 
D  1  "  D  1 day 
D1  "  D1  " 
D1  "  S 
S  S 
S  D  2 days 
S  D  3  " 
S  S 
S  S 
D  1 day  D  1 day 
D  7 days  S 
S  S 
S  S 
S  D  10 days 
S  S 
S  S 
S  S 
S  S 
S  S 
S  S 
S  S 
S  S 
S  S 
S  S 
S  S 
D1 day 
D1  " 
D2 days 
D2  " 
Dlday 
D1  " 
D1  " 
S 
D1 day 
D1  " 
D2 days 
S 
D  lday 
D1  " 
D1  " 
D1  " 
D  1  ~ 
D1  " 
D1  " 
D  2 days 
D1 day 
D2 days 
D3  " 
D5  " 
18  to  20  gin.  mice were  injected intraperitoneaUy with 0.5  cc.  of  the  serum 
indicated, the day before inoculation.  Fresh 12 hour blood broth cultures were 
diluted serially with broth so that 0.5 cc. contained the desired dose.  The amounts 
recorded were injected intraperitoneaUy into four mice in each set.  Similar sets 
of mice which had received no serum were included as virulence controls. 
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given to mice.  On the following  day all  the mice were inoculated  with varying 
amounts of strain  SI18. 
TABLE  V 
Precipitin Reactions 
Antisera Prepared with Extracts 
Serum 
Rabbit R47-08 anti- 
Sl18  extract 
(type 1) 
0,2 cc. 
,,  ,c 
g¢  gc 
Rabbit R47-23 anti- 
D58  extract 
(type 3) 
0.2 cc. 
M extracts for precipitin tests 
Grou.p- 
speelllC 
Type 14 strains  C 
fraction 
Type l  strains  Type 3  strains 
s~_  _  c~o3! Tj-_  s~3 
4- 
1-4-  -- 
1-4- 
1-+ 
7 
4-  ++  +4- 
4-  4-  i 
m 
m 
m 
The M  extracts used here were prepared by heating at  100°C. with N/20 HC1 
and  after alcohol precipitation  were made  up  in a  final concentration  of  about 
one-fifth  of  the  original  volume of  extracts.  Serial  dilutions  were  made  with 
saline  in 0.4  cc.  volume.  To each  tube  0.2  cc.  of serum  was  added,  they  were 
then incubated  at 37 °  for 2  hours  and  kept in  the refrigerator overnight before 
reading.  Readings  were  made  on  a  scale  of  +  +  +  +  to  4-.  The  C  fraction 
used here was made from the type 6 strain $43 by acid extraction and the protein 
removed with HgCI~.  In the concentrations used here it gave strong precipitin 
reactions with sera potent in anti-C. 
Strain  $43  was  isolated  in Texas  in  1918  from  the  throat  of  a  patient  with 
measles. 
* Strain  T3  is  Griffith's  strain  "Lewis opaque,"  kindly  sent  by  Dr.  Griffith 
as a  representative of type 3.  It was given 40 passages through mice to increase 
its virulence and  its content of type-specific substance. GEORGE  K.  HIRST  AND  REBECCA  C.  LANCEFIELD  439 
The  results  of  the  absorption  experiment recorded  in  Table  VI, 
indicate that the lot 61 extract removed the protective antibody from 
the antibacterial serum so that even in doses of 0.5  cc.  the absorbed 
serum no  longer protected against as  little as  100  M.L.D. (10  -5  CC.) 
of a strain of homologous type.  The absorption with the M substance, 
extracted  at  100  °  with N/20  HC1,  was only slightly  less  complete: 
0.5  cc.  of this absorbed serum protected only against 100  and  1,000 
M.L.D. and  not  against  larger  doses  of  culture.  This  amount  of 
protection  was  insignificant when  compared  with  the  original titer 
of the serum which was high enough for 0.06 cc.  to protect a  mouse 
against 100,000  M.L.D. 
Active Immunization of Mice with M  Extracts 
The hypothesis that the M  substance is essentially similar to the 
antigenic substance in extracts active in inducing immunity was also 
tested by the following experiment. 
Mice were immunized actively with M extracts prepared by heating living 
streptococci with N/20 HC1 for 15 minutes in a boiling water bath.  The antigen 
was further purified by reprecipitating twice from saline solution with three to 
four volumes of 95 per cent ethyl alcohol.  A neutral solution of the antigen was 
filtered through a Berkefeld N filter; and the amount to be injected was calcu- 
lated on the basis of the trichloroacetic acid precipitable fraction.  The antigen 
was distributed in tubes, each containing enough for one day's immunization, 
and dried from the frozen state on the Flosdorf-Mudd lyophile apparatus. 
In Table VII  are  recorded  the results of testing mice immunized 
with the extract.  One set of animals received 0.33  rag. of material, 
the same dosage as those recorded in Tables I  and II.  Only 20 per 
cent of these survived an inoculation of 100 M.L.D. of the homologous 
strain  Sl18.  In  another  set  which  was  immunized  with  6.6  mg., 
60 per cent survived a  similar inoculum.  A preliminary test with a 
similar M  extract,  but  unfiltered, also  showed 60  per  cent  survival 
when large immunizing doses were given for 4 weeks. 
Preliminary Chemical Studies of the Antigenic Extract 
Total nitrogen and phosphorus analyses on three  typical extracts 
are given in Table VIII.  Since the high phosphorus content and the 
precipitability at pH 4.5 suggested that nucleic acid might be present, 440  GROUP  A  HEMOLYTIC  STREPTOCOCCI 
spectroscopic  examination  of  several  preparations  was  made.  s  All 
showed an absorption spectrum characteristic of nucleic acid, that is, 
a wide band with maximal absorption at about 2,600 It.  Quantitative 
spectroscopic estimates,  using yeast nucleic acid  as  a  standard,  in- 
TABLE  VI 
A bsorption Experiment 
Passive Protection Test in Mice 
Type 1 antibacterial serum 
Unabsorbed 
cc, 
0.5 
0.25 
0.12 
0.06 
10-2 cc. 
Culture: Type 1, strain Sl18 
10-3 cc.  10-4 cC. 
S  S 
S  S 
S  S 
D 3 days  D  2 days 
10-6 cc. 
S 
S 
D  2 days 
D  12  " 
Absorbed with type 1, Sl18 
extract:  Lot  61  antigen 
used for active and pas- 
sive immunization tests 
Absorbed with type 1, Sl18 
M  extract,  made with 
N/20 HC1 at 100°C. 
0.03 
0.5 
0.25  I 
0.12 
0.06 
0.03 
0.5 
0.25 
0.12 
0.06 
0.03 
D  3 days 
D  1 day 
D1  " 
D1  " 
D1  " 
D1  " 
D  1  " 
D1  " 
D1  " 
D1  " 
D1  " 
D  3 days 
D  2  " 
D  1 day 
D1  " 
D1  " 
D  1  " 
D  2 days 
D  1day 
D1  " 
D1  " 
D  2  " 
D  1 day 
D  2 days 
D  1 day 
D  2 days 
D  2  " 
S 
D  2 days 
D  2  " 
D  1 day 
D  2 days 
D  1 day 
D  2 days 
D  2  " 
D  2  " 
Dlday 
S 
D  2 days 
D  5  " 
D  3  " 
D  3  " 
Virulence controls: Inoculated with strain S118 
20 mice inoculated with 10-6 cc.  6 mice inoculated with 10  --7 cc.  6 mice inoculated with 10-s cc. 
10 mice D  1 day 
8  "  D  2 days 
2  "  S 
3 mice D 2 days 
1 mouse D  5  " 
2 mice S 
6 mice S 
dicated that usually 25 to 30 per cent of the material in the extracts 
was nucleic acid.  The biuret test and the Sakaguchi test for arginine 
were positive in high dilutions of the extracts.  Since the relationship 
s We are indebted to Dr.  George Lavin for the spectroscopic determinations 
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TABLE  VII 
Active Protection  Test in Mice 
Immunized  with M  Extract*  of Strain $118 
441 
Immunized mice: Immunity tested by inoculating with 104 ce. strain Sl18 
Each mouse immunized with  Each mouse immunized with 
Mouse No.  total dosage 0.33 nag. of extract  total dosage 6.6 rag. of extract 
5 
6 
7 
8 
9 
10 
D  lday 
D1  " 
D1  " 
D  2 days 
D  4  " 
D  4  " 
D  4  " 
D  4  " 
S 
S 
D  1 day 
D1  " 
D  2 days 
D  4  " 
S 
S 
S 
S 
S 
S 
Virulence controls:  Inoculated with strain Sl18 
20 mice inoculated with 104 ec.  5 mice inoculated with 10-7 co.  5 mice inoculated with 10-8 co. 
16mice  D  1day 
2  "  D  2 days 
lmouseD  5  " 
1  "  D  12  " 
2 mice D  1 day 
3  "  D  2 days 
4mice  D2days 
I  mouse  S 
Immunization  was carried  out in  the same manner  as with the mice reported 
in Table I,  each set receiving four series of injections. 
* Extract  prepared  by heating at  100°C. with N/20 HC1. 
TABLE  VIII 
Chemical Analysis of Typical Fractions  Used for Immunization 
Lot No. 
61 
62 
65 
Extract from 
Strain Sl18  Type 1 
"  D58  "  3 
"  Sl18  "  1 
Organisms 
heated 
at 56"C. 
rain. 
15 
15 
5 
N 
per cent 
16.73 
15.60 
16.25 
tated by  I 
P  trichloro-  I 
per cent 
3.97  [  52.06 
i 
3.69  [  50.61 
3.40  I  58.72 
Nucleic 
acid 
~er Cent 
33.3 
6.9 
30.2 
of these  findings  to  the  constitution  of  the  active  agent  in  the  extract 
is not  certain,  further  work  is being  carried  on  in an  attempt  to  clarify 
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DISCUSSION 
A  substance has been obtained from extracts of group A hemolytic 
streptococci  which induces  active  immunity in  mice.  On  injection 
into  rabbits  it  leads  to  the  production  of  relatively  type-specific 
antibody  with  which  mice  may  be  passively  protected  against  in- 
fection with strains of the homologous type.  Although the immunity 
in  general  was  predominantly  type-specific  in  nature,  some  non- 
type-specific reactions were also observed.  It is important to realize 
that  the  methods  employed  for  extracting  the  streptococci  would 
probably not yield any single substance in a form approaching purity. 
This conception is strengthened by the previous work which suggests 
that  the hemolytic streptococcus contains many proteins which are 
precipitable at a pH near 4.5 (2) and this idea is, moreover, confirmed 
by the cross reactions seen in precipitin tests with some of the antisera 
obtained from rabbits  immunized with this material.  Although the 
first  experiment  (Table  I)  indicated  active  protection  against  the 
homologous strain, the second experiment (Table II) showed that this 
was  not  strictly  type-specific.  This  cross  immunity  may  be  ex- 
plained by assuming either that it was induced by other antigens in 
the immunizing extracts having a  broader specificity than the type- 
specific substance or that there are  chemical and antigenic relation- 
ships among the type-specific substances themselves. 
In  the  passive  protection  experiments,  on  the  other  hand,  type- 
specific immunity was striking, and the indication of cross protection 
among  types  so  slight  that  its  existence  is  questionable.  In  the 
precipitin tests with  the immune sera  prepared in  rabbits  and  used 
for passive protection tests in mice  (Table  V),  both type specificity 
and cross reaction were observed.  The cross reactions here are open 
to the same interpretation as in the experiment on active immunity. 
Although precipitin  absorptions  were  not  performed in  the  present 
experiments, previous work based on absorption experiments indicates 
that cross reactions observed in the precipitin test are probably due 
to an admixture of antigens in the extract used to immunize animals, 
and,  correspondingly in  the  M  extract  used as  reagents  in  the  test 
tube. 
In  developing a  method of  extracting  the  antigen,  different pro- 
cedures were tried, and the extracts were compared in their ability to GEORGE  K. HIRST  AND  P..EBECCA  C. LANCEFIELD  443 
produce immunity in mice.  While the method used in  the  present 
experiments was the best of those tried, there are certain steps in the 
procedure which were used empirically.  In  the light of experience 
gained since this method was adopted, it may be that heat-killing and 
grinding the  bacteria  prior  to  extraction  are  not essential  steps in 
obtaining the best antigens.  We feel that it is important, however, 
to  use  young,  actively  growing cultures,  prepared  by  the  method 
described.  The  comparative  experience  in  immunizing  rabbits, 
which shows that large doses of antigenic extract did not induce as 
potent antisera as smaller doses of whole streptococci, makes us feel 
that the antigenicity of the active substance had been impaired by 
extraction.  Possibly some refinement of these extraction methods or 
a different procedure may furnish an antigen with unimpaired or little 
diminished activity. 
The nitrogen and phosphorus analyses of the extracts, the positive 
protein tests, and the spectroscopic analyses, as well as the behavior 
of the extracts in precipitating at pH 4.5, all suggest the presence of a 
nucleoprotein.  It is impossible to say at present whether a  nucleo- 
protein is the agent active in inducing the immunity observed, since 
the  extracts  were  undoubtedly  impure  preparations.  Conceivably 
a  very small admixture of some other substance may have been re- 
sponsible for the antigenic activity. 
The antigen we have extracted cannot, as yet, be compared with the 
labile antigen described by Mudd and his coworkers,  1 since they have 
studied that fraction mainly in its ability to absorb precipitins, ag- 
glutinins,  opsonins, and  of  protective  antibodies  from antibacterial 
serum, while we have confined ourselves principally to the production 
of  active  immunity in  mice  and  protective  antibodies  in  rabbits. 
Sevag,  Lackman,  and  Smolens  (18)  have  recently  stated  that  the 
labile antigen is a  nucleoprotein.  While the active agent in the ex- 
tracts described by us may be a nucleoprotein, it does not necessarily 
follow that it is the same as the labile antigen, since it is known that 
there are many nucleoproteins in the streptococcus (2), some of which 
are undoubtedly non-type-specific in nature. 
The extract studied by Stamp and Hendry, however, is similar to 
the one described here, since both are made with •/10  HC1 at 37°C. 
Although the subsequent method of purification is different, both ex- AAA  GROUP  A  HEMOLYTIC  STR~PTOCOCCI 
tracts produce active immunity in mice against the homologous strain 
of streptococcus. 
The active protection experiment in mice with the type-specific M 
substance extracted with N/20 HC1 in a boiling water bath, shows that 
antigenic material is present, even though it is necessary to give larger 
amounts of it  to obtain  a  degree of protection comparable to  that 
elicited by the extract described in this paper.  Both kinds of extracts 
react similarly in precipitin tests with specific immune sera, and both 
are also similar in the way they absorb the protective substance from 
immune sera.  This last finding is at variance with the conclusions 
of Mudd and his collaborators, who were unable to absorb the pro- 
tective substance from antibacterial sera with M  substance prepared 
as  described  above. 
The evidence presented,  together with the general characteristics 
of the substance and manner of isolation, leads us to believe that the 
active principle in the extracts used for active and passive immuniza- 
tion  in  the  present  experiments is  essentially similar to  the  active 
principle in the M  extracts as formerly prepared, and probably also 
to the antigenic substances obtained by Stamp and Hendry, although 
different preparations exhibit varying degrees of purity and degrada- 
tion  from  the  native  state.  This  substance,  immunologically dis- 
tinct for each serological type of group A hemolytic streptococcus, is 
probably the type-specific constituent in at least partially antigenic 
form. 
SIYMM.AR¥ 
1.  A substance extracted from group A hemolytic streptococcus is 
described, which induces active immunity in mice, and in rabbits gives 
rise to precipitins and to protective antibodies passively transferable 
to mice. 
2.  The  active  immunity in mice is  principally  type-specific,  but 
some degree of non-type-specific immunity is also developed.  The 
passively transferable protective antibodies are type-specific with only 
a  slight  suggestion  of  non-type  specificity.  In  the  precipitin  test, 
the rabbit immune sera give both type-specific and non-type-specific 
reactions which have not been fully analyzed serologicaUy. 
3.  Substances contained in the extract absorb the protective anti- 
bodies from the  serum of rabbits  immunized with whole hemolytic 
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4.  The  most satisfactory  method  of extraction  so far developed  is 
fully described.  Chemical  tests  on  the  material  are  consistent  with 
the presence of protein  and nucleic  acid. 
5.  The type-specific M  substance, prepared as previously described, 
was  compared  in  some  of  its  antigenic  properties  with  the  above 
mentioned  substance.  It  was  found  capable  of  inducing  active 
immunity  in  mice  and  of  absorbing  protective  antibody  from  anti- 
bacterial  immune  serum  in  a  manner  qualitatively  similar  to  that 
obtained with the preparations  made by the newer methods. 
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